Rottapharm
Rottapharm is a privately held Italian pharmaceutical company headquartered in Monza, with origins in a 1961 research laboratory and a 5,001–10,000 employee workforce. It is historically known for developing Nimesulide, a proprietary NSAID launched in Italy in the 1980s.
- Company typePrivate
- Founded1980
- HeadquartersMonza, Italy
- Headcount5,001–10,000
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
Rottapharm firmographics
Firmographics- Name
- Rottapharm
- Website
- https://rotta.com
- Company type
- Private
- Founded year
- 1980
- Headcount range
- 5,001–10,000 employees
- Short description
- Rottapharm is a privately held Italian pharmaceutical company headquartered in Monza, with origins in a 1961 research laboratory and a 5,001–10,000 employee workforce. It is historically known for developing Nimesulide, a proprietary NSAID launched in Italy in the 1980s.
- Ownership category
- akta.pro rank
Rottapharm industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Aseptic Processing, Fill-Finish & Sterile Manufacturing Tech (isolators, lyophilization interfaces) (HLAAAJAG)
- akta.pro secondary industries
- Drug Product Fill-Finish & Aseptic Manufacturing Services (HLAAAKAB), General Lab Equipment (Centrifuges, Incubators, Shakers, Ovens) (HLAGAIAC), Pharmaceutical & Biologics Frozen Storage (Ultra-Low/Deep-Freeze) (TLALACAD)
Keywords
Where Rottapharm is headquartered
LocationHeadquarters
- HQ city
- Monza
- HQ country
- Italy
- HQ region
- Europe
Markets served
Rottapharm business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales
Rottapharm product offering
Product offeringCore offering
Rottapharm is a pharmaceutical company that originates from a small independent research laboratory founded in 1961 in Italy. It develops and manufactures drug products, with Nimesulide (an anti-inflammatory drug developed in Italy in the 1980s) being the specifically identified product in the source material. The company is structured as a private for-profit entity headquartered in Monza, Italy, employing 5,001–10,000 people.
Differentiator
Problem solved
Functional benefit
Products and services
- Nimesulide Nimesulide is an anti-inflammatory drug developed in Italy in the 1980s, associated with Rottapharm's research legacy. It is indicated for the treatment of inflammatory conditions. Specific indications and dosage forms are not described in the provided source.
Companies that use Rottapharm
Customer profileIdeal customer profiles2 records
Rottapharm technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Rottapharm competitors and assessment
Company assessmentBroad incumbents
- Almirall: European (Spanish) specialty pharmaceutical company focused on branded dermatology and specialty products. Comparable to Rottapharm in proprietary branded pharma strategy and EU-centric footprint.
- Chiesi Farmaceutici: Family-owned Italian pharmaceutical company with strong R&D, branded specialty pharma, and a respiratory/rare-disease focus. Comparable on private status, Italian manufacturing base, and research-driven branded-drug model.
- Menarini Group: Privately-held Italian pharmaceutical group with branded specialty products, manufacturing in Italy, and global distribution. Matches Rottapharm's combination of Italian heritage, branded focus, and large employee base.
- Zambon: Italian privately-held pharmaceutical company focused on branded specialty products and inhalation/CDMO services. Comparable to Rottapharm in proprietary pharma manufacturing and European distribution.
- Angelini Pharma: Privately-held Italian pharma group (part of Angelini Industries) with branded CNS and consumer health products. Comparable to Rottapharm via private ownership, Italian manufacturing, and branded Rx portfolio.
- Mylan (now Viatris): Large global pharmaceutical manufacturer (formed via Mylan–Upjohn merger) with significant manufacturing in Italy and a broad specialty/generics portfolio. Comparable on European manufacturing scale and pharma ops.
- Recordati: Italian specialty pharmaceutical company headquartered near Milan with a branded prescription portfolio across Europe. Highly comparable to Rottapharm in therapeutic focus, Italian/European footprint, and mid-large operational scale.
Regional players
- Laboratorio Italiano Biochimico (L.I.B.): Italian pharmaceutical manufacturer specializing in injectable and sterile drug product manufacturing. Comparable to Rottapharm on Italian manufacturing heritage and sterile/fill-finish capabilities implied by industrial scale.
Market position
Customer concentration
Rottapharm social profiles
Digital presenceRottapharm financial estimates
Financial estimateRevenue estimate
Valuation estimate
Rottapharm leadership team
Management profileNumber of profiles
Rottapharm funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Rottapharm M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Rottapharm
What does Rottapharm do?
Rottapharm is a pharmaceutical company that originates from a small independent research laboratory founded in 1961 in Italy. It develops and manufactures drug products, with Nimesulide (an anti-inflammatory drug developed in Italy in the 1980s) being the specifically identified product in the source material. The company is structured as a private for-profit entity headquartered in Monza, Italy, employing 5,001–10,000 people.
When was Rottapharm founded?
Rottapharm was founded in 1980. It employs 5,001 to 10,000 people.
Where is Rottapharm based?
Rottapharm is headquartered in Monza, Italy, in the Europe region.
Who are Rottapharm's main competitors?
Broad incumbents on record are Almirall, Chiesi Farmaceutici, Menarini Group, Zambon, Angelini Pharma, Mylan (now Viatris) and Recordati. Laboratorio Italiano Biochimico (L.I.B.) is listed as a regional player.
Does Rottapharm have an API?
No public API is recorded for Rottapharm.
What industry is Rottapharm in?
Rottapharm's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAAAJAG, Aseptic Processing, Fill-Finish & Sterile Manufacturing Tech (isolators, lyophilization interfaces), with a secondary code of HLAAAKAB, Drug Product Fill-Finish & Aseptic Manufacturing Services. Its NAICS code is 325412 and its SIC code is 8731.